Streetbeat News

Analyst Ratings

MKC

Barclays analyst Andrew Lazar maintains an Equal-Weight rating on McCormick & Co (NYSE:MKC) and raises the price target from $77 to $85.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2023 | 9:51 am

AZN

DSKNY

AstraZeneca reported high-level results from the TROPION-Lung01 Phase 3 trial of datopotamab deruxtecan (Dato-DXd) in patients with advanced or metastatic non-small cell lung cancer. The drug showed a statistically significant improvement for progression-free survival compared to the current standard of care chemotherapy. However, some adverse events were observed, including some Grade 5 events (Death related to AE), which may be causing investor concern. The drug is jointly developed by AstraZeneca and Daiichi Sankyo.

Portfolio Pulse from Vandana Singh

July 03, 2023 | 9:50 am

IPG

B of A Securities analyst Adrien de Saint Hilaire maintains a Buy rating on Interpublic Gr of Cos (NYSE:IPG) and raises the price target from $40 to $44.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2023 | 9:48 am

TSLA

Citigroup analyst Itay Michaeli has reiterated a Neutral rating on Tesla, maintaining a price target of $215.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2023 | 9:47 am

ETNB

BTIG analyst Justin Zelin maintains a 'Buy' rating on 89bio (NASDAQ:ETNB) and raises the price target from $30 to $37.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2023 | 9:33 am

TSLA

Tesla reported record-breaking Q2 production and delivery numbers, but Future Fund's Gary Black believes the stock will rise further. Despite concerns about Tesla's aggressive price cuts to boost volume, Black maintains that a beat is a beat. However, he expresses concern over Tesla's strategy of offering early-quarter discounts, suggesting instead that the company should explore new advertising strategies promoting electric vehicle adoption.

Portfolio Pulse from Shanthi Rexaline

July 03, 2023 | 9:19 am

LAZ

Wolfe Research analyst Steven Chubak has upgraded Lazard (NYSE:LAZ) from Underperform to Peer Perform.

Portfolio Pulse from richadhand@benzinga.com

July 03, 2023 | 9:17 am

ACMR

ACM Research shares are trading higher after Jefferies upgraded its rating from Underperform to Buy and raised the price target from $9 to $23.4.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2023 | 9:05 am

TSLA

Wedbush analyst Daniel Ives has reiterated an Outperform rating on Tesla (NASDAQ:TSLA) and maintained a $300 price target.

Portfolio Pulse from richadhand@benzinga.com

July 03, 2023 | 8:36 am

ACMR

Jefferies analyst Nick Cheng has upgraded ACM Research (NASDAQ:ACMR) from Underperform to Buy and raised the price target from $9 to $23.4.

Portfolio Pulse from richadhand@benzinga.com

July 03, 2023 | 8:29 am